Protein Sciences Corporation, along with The Connecticut Association for Healthcare at Home (CTH@H), announced a new partnership today that will bring Flublok® influenza vaccine to home health and hospice agencies across the state. As a new affinity partner of CTH@H, Protein Sciences will make Flublok available to CTH@H member agencies for the 2015/16 flu season.
"The Connecticut Association for Home Healthcare is the united voice for home and community-based care delivery in the state. This partnership brings new opportunities to create awareness for Flublok from a ground-up perspective," said Manon Cox, President and CEO of Protein Sciences Corporation. "Entering into an affinity partnership with CTH@H is an exciting opportunity to inform and engage the community-based workforce about Flublok and its unique features for their patients."
"Ensuring that Connecticut's 20,000 home health and hospice agency employees have access to the Flublok vaccine for both their patient population as well as for themselves is a positive step toward the goal of limiting exposure and spread of the flu," said Deborah Hoyt, President and CEO of the Connecticut Association for Healthcare at Home. "Home health workers are on the front line in terms of reaching the most vulnerable patients – the frail, homebound and disabled - making this new relationship with Protein Sciences a strategic step toward improving population health in Connecticut.
MassiveFold advances protein structure prediction with efficient parallel processing